| 1 |
29632053 | Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors. | 2018 Apr |
1 |
| 2 |
29744614 | A case of epidural glioblastoma metastasis presenting with a cervical myelopathy, torticollis, and L'hermitte's phenomenon. | 2018 Jul |
1 |
| 3 |
28622068 | Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide. | 2017 Jul 3 |
1 |
| 4 |
26538496 | Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer. | 2016 Jun |
1 |
| 5 |
25667500 | Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG). | 2015 Feb |
1 |
| 6 |
25835050 | c-Myc modulation: a key role in melanoma drug response. | 2015 |
1 |
| 7 |
26497996 | IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide. | 2015 Nov 24 |
1 |
| 8 |
24941944 | Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells. | 2014 Jun 19 |
1 |
| 9 |
23564767 | PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor. | 2013 Apr |
1 |